LS Investment Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

LS Investment Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,029	Closed	-$22K	–	1893
2017 Q2	$22K	Hold	1,029	–	–	﹤0.01%	1565
2017 Q1	$14K	Hold	1,029	–	–	﹤0.01%	1650
2016 Q4	$19K	Hold	1,029	–	–	﹤0.01%	1574
2016 Q3	$17K	Hold	1,029	–	–	﹤0.01%	1571
2016 Q2	$14K	Hold	1,029	–	–	﹤0.01%	1602
2016 Q1	$16K	Hold	1,029	–	–	﹤0.01%	1546
2015 Q4	$20K	Buy	1,029 +101	+11%	+$1.92K	﹤0.01%	1492
2015 Q3	$16K	Buy	928 +125	+16%	+$2.54K	﹤0.01%	1549
2015 Q2	$16K	Buy	+803	New	+$15.5K	﹤0.01%	1580

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

LS Investment Advisors's AMRI Position: Q3 2017 in Review

LS Investment Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 1,029 shares — an estimated $22K sold.

LS Investment Advisors first reported a position in AMRI in Q2 2015 and held it in 9 quarters. The position peaked at $22K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

LS Investment Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
LS Investment Advisors sold 1,029 Albany Molecular Research Inc shares in Q3 2017, an estimated $22K.
LS Investment Advisors first reported a position in Albany Molecular Research Inc in Q2 2015 and held it in 9 quarters.
LS Investment Advisors's Albany Molecular Research Inc position peaked at $22K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on LS Investment Advisors's 13F filing for Q3 2017, filed 19 Oct 2017.